Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Lakhdar Arab is active.

Publication


Featured researches published by Lakhdar Arab.


Archive | 2004

CXCR4 antagonist treatment of hematopoietic cells

Christopher R. Tudan; Ahmed Merzouk; Lakhdar Arab; Geeta Saxena; Connie J. Eaves; Johanne Cashman; Hassan Salari; Ian Clark-Lewis


Journal of Medicinal Chemistry | 2002

C-Terminal Cyclization of an SDF-1 Small Peptide Analogue Dramatically Increases Receptor Affinity and Activation of the CXCR4 Receptor

Christopher R. Tudan; Gordon E. Willick; Sarabjit Chahal; Lakhdar Arab; Ping Law; Hassan Salari; Ahmed Merzouk


Archive | 2001

CXCR4 agonist treatment of hematopoietic cells

Christopher R. Tudan; Ahmed Merzouk; Lakhdar Arab; Geeta Saxena; Connie J. Eaves; Johanne Cashman; Ian Clark-Lewis; Hassan Salari


Archive | 2002

CXC chemokine receptor 4 agonist peptides

Christopher R. Tudan; Ahmed Merzouk; Lakhdar Arab; Geeta Saxena; Connie J. Eaves; Johanne Cashman; Ian Clark-Lewis; Hassan Salari


Archive | 2001

use of cxcr4 antagonists for treating autoimmune diseases and cancer

Christopher R. Tudan; Ahmed Merzouk; Lakhdar Arab; Geeta Saxena; Connie J. Eaves; Johanne Cashman; Ian Clark-Lewis; Hassan Salari


Archive | 2009

Treatment of liquid cancers

Christopher R. Tudan; Ahmed Merzouk; Lakhdar Arab; Geeta Saxena; Connie J. Eaves; Joanne Cashman; Ian Clark-Lewis; Mary A. Richter; Michael Clark-Lewis; Hassan Salari


Archive | 2009

Purging of an ex vivo hematopoietic stem cell culture of cancer cells

Christopher R. Tudan; Ahmed Merzouk; Lakhdar Arab; Geeta Saxena; Connie J. Eaves; Joanne Cashman; Ian Clark-Lewis; Mary A. Richter; Michael Clark-Lewis; Hassan Salari


Archive | 2001

BEHANDLUNG VON HEMATOPOIETISCHEN ZELLEN MIT CXCR4 AGONISTEN

Lakhdar Arab; Johanne Cashman; Ian Clark-Lewis; J. Connie Eaves; Ahmed Merzouk; Hassan Salari; Geeta Saxena; R. Christopher Tudan


Archive | 2001

Verwendung von cxcr4 antagonisten zur behandlung von krebs und autoimmunkrankheiten Use of CXCR4 antagonist for the treatment of cancer and autoimmune disease

R Tudan; Ahmed Merzouk; Lakhdar Arab; Geeta Saxena; J Eaves; Johanne Cashman; Ian Clark-Lewis; Hassan Salari


Archive | 2001

Behandlung von hematopoietischen zellen mit cxcr4 agonisten Agonist treatment of hematopoietic cells with cxcr4

Hassan Salari; Ahmed Merzouk; Lakhdar Arab; R Tudan; Geeta Saxena; J Eaves; Johanne Cashman; Ian Clark-Lewis

Collaboration


Dive into the Lakhdar Arab's collaboration.

Top Co-Authors

Avatar

Hassan Salari

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

Geeta Saxena

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

Ian Clark-Lewis

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

Johanne Cashman

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

Ahmed Merzouk

Fred Hutchinson Cancer Research Center

View shared research outputs
Top Co-Authors

Avatar

Christopher R. Tudan

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

Connie J. Eaves

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

J. Connie Eaves

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

R. Christopher Tudan

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

Ahmed Merzouk

Fred Hutchinson Cancer Research Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge